Bio Rad Laboratories Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Bio Rad Laboratories Inc's ROI in the third quarter of 2026?
Bio rad Laboratories Inc achieved a return on average invested assets (ROI) of 10.76 % in its third quarter of 2026, this is above BIO's average return on investment of 5.45%.
Bio Rad Laboratories Inc s investments during the 12 months ending in the third quarter of 2026 are valued at $9 billion

ROI has improved compared to 2.38% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 55 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 1204 to 2080.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Investment Change TTM	2.42 %	-1.77 %	1.46 %	-5.07 %	-14.08 %
Y / Y Net Income Change TTM	-	-30.32 %	12221.17 %	-	-
Investment (TTM) in Millions	9,814	9,291	8,873	10,060	9,174
Return On Investment (TTM)	10.76 %	2.38 %	1.78 %	7.94 %	-7.28 %
BIO's Overall Ranking	# 2080	# 1204	# 3088	# 1593	# 3546
Seq. Investment Change TTM	1.71 %	-1.49 %	-0.89 %	3.13 %	-2.45 %
Seq. Net Income Change TTM	359.94 %	31.75 %	-77.79 %	-	-
Net Income (TTM) in Millions	1,023	222	169	760	-676

BIO Company Profile >> Back to BIO Roi Comparisons >> See Annual BIO Return On Investment

Return On Investment BIO's Ranking
Within:	No.
Industry	# 3
Sector	# 56
Overall	# 2080

Return On Investment Statistics
High	Average	Low
44.26 %	5.45 %	-43.87 %
(Sep 30 2021)		(Sep 30 2022)

News about Bio rad Laboratories Inc Return on Investment ROI

Bio-Rad Laboratories Appoints Roop K. Lakkaraju as CFO to Drive Financial Transformation and Growth

March 20, 2024

Bio-Rad Laboratories Appoints Roop K. Lakkaraju as Executive Vice President and Chief Financial Officer
Hercules, California - Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a renowned global leader in life science research and clinical diagnostics products, is pleased to announce the appointment of Roop K. Lakkaraju as its new Executive Vice President and Chief Financial Officer. This strategic move comes as Bio-Rad aims to strengthen its financial management and drive growth in the highly competitive industry. Mr. Lakkaraju, formerly serving as the Executive Vice President and Chief Financial Officer at Benchmark Electronics, brings a wealth of experience and expertise to his new role. He will officially assume the position on April 15, 2024.
Having worked in the multi-national electronics manufacturing services sector, Mr. Lakkaraju is no stranger to the complexities of the industry. His extensive background in financial management and strategic planning will undoubtedly support Bio-Rad s vision of advancing scientific discovery and improving healthcare outcomes through innovative solutions.

Financial Statements
Bio Rad Laboratories Inc's III. Quarter Investments	$ 9,814 Millions	BIO's Balance sheet
Bio Rad Laboratories Inc's III. Quarter Income	$ 459 Millions	Quarterly BIO's Income Statement
BIO's Income by Division		See BIO's Income by Division

BIO Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	10,060	8,896	11,776	12,933	17,095
Y / Y Investment Growth	13.08 %	-24.46 %	-8.94 %	-24.35 %	38.52 %
Net Income in Millions	760	-1,844	-637	-3,628	4,246
Y / Y Net Income Growth	-	-	-	-	11.55 %
Annual Return On Investment	7.55 %	-20.73 %	-5.41 %	-28.05 %	24.84 %

Annual Roi Comment

In the fiscal year 2025 ROI improved to 7.55 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BIO's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BIO's Competitors
Subscribers only: Roi for Bio Rad Laboratories Inc's Suppliers
Subscribers only: Return On Investment for BIO's Customers

Other Ratios
BIO's Roa	BIO's Inventory Turnover Ratio	BIO's Growth Rates	BIO's Dividend Statistics
	BIO's Profitability Ratios	BIO's Asset Turnover Ratio	BIO's Dividend Growth
BIO's Roe	BIO's Valuation Ratios	BIO's Financial Strength Ratios	BIO's Dividend Payout Ratio

Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector	ROI
Acadia Pharmaceuticals Inc	26.89 %
Protalix Biotherapeutics inc	26.06 %
Standard Biotools Inc	23.91 %
Electromed Inc	23.41 %
Iradimed Corporation	22.98 %
Corcept Therapeutics Inc	22.08 %
Resmed Inc	21.10 %
Alector Inc	20.83 %
Chemed Corporation	20.46 %
Halozyme Therapeutics Inc	19.64 %
Pro dex Inc	19.11 %
Dexcom Inc	18.92 %
Illumina Inc	18.74 %
Denali Therapeutics Inc	17.88 %
West Pharmaceutical Services Inc	17.65 %
Healthcare Services Group Inc	17.18 %
Neurocrine Biosciences Inc	16.94 %
Krystal Biotech Inc	16.91 %
Vertex Pharmaceuticals Inc	16.63 %
Sanuwave Health Inc	16.50 %
Intuitive Surgical Inc	16.30 %
Hca Healthcare Inc	15.54 %
Kiniksa Pharmaceuticals International Plc	15.45 %
Amgen Inc	13.64 %
Carlisle Companies Incorporated	13.64 %
Bristol myers Squibb Company	13.59 %
3m Company	13.24 %
Alpha Pro Tech Ltd	13.18 %
Beone Medicines Ltd	13.17 %
Regeneron Pharmaceuticals Inc	13.00 %

Date modified: 2026-11-08T19:11:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.